DATASCOPE CORP, DEF 14A, 1999-10-28

DATASCOPE CORP
DEF 14A, 1999-10-28
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Previous: IAA TRUST GROWTH FUND INC, 485BPOS, 1999-10-28

Next: DREYFUS A BONDS PLUS INC, 497, 1999-10-28

<PAGE>

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12

Datascope Corp.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)

- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[X] No fee required.

[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

1) Title of each class of securities to which transaction applies:

2) Aggregate number of securities to which transaction applies:

3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined):

4) Proposed maximum aggregate value of transaction:

5) Total fee paid:

[ ] Fee previously paid with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.

1) Amount Previously Paid:

2) Form, Schedule or Registration Statement No.:

3) Filing Party:

4) Date Filed:

<PAGE>

DATASCOPE CORP.
14 Philips Parkway
Montvale, New Jersey 07645

---------------

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
DECEMBER 7, 1999

---------------

NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders of
Datascope Corp. (the "Corporation") will be held at 11:00 o'clock a.m., local
time, on December 7, 1999, at The Harmonie Club, 4 East 60th Street, New York,
New York, for the following purposes:

1. To elect two directors of the Corporation to hold office until
the next Annual Meeting of Shareholders and until the election
and qualification of their respective successors;

2. To consider and vote upon a proposal to amend the
Corporation's 1995 Stock Option Plan (the "1995 Stock Option
Plan") to increase the number of shares of the Corporation's
common stock, $.01 par value per share ("Common Stock"), which
may be the subject of options granted pursuant to the 1995
Stock Option Plan from 1,500,000 shares in the aggregate to
2,750,000 shares in the aggregate; and

3. To transact such other business as may properly come before the
meeting.

Only holders of record of the Corporation's Common Stock at the close
of business on October 27, 1999 are entitled to notice of, and to vote at, the
meeting and any adjournment thereof. Such shareholders may vote in person or by
proxy.

SHAREHOLDERS WHO FIND IT CONVENIENT ARE CORDIALLY INVITED TO ATTEND THE
MEETING IN PERSON. IF YOU ARE NOT ABLE TO DO SO AND WISH THAT YOUR STOCK BE
VOTED, YOU ARE REQUESTED TO FILL IN, SIGN, DATE AND RETURN THE ACCOMPANYING
PROXY IN THE ENCLOSED ENVELOPE. NO POSTAGE IS REQUIRED IF MAILED IN THE UNITED
STATES.

By Order of the Board of Directors,

MURRAY PITKOWSKY,
Secretary

Dated: November 1, 1999

<PAGE>

DATASCOPE CORP.
14 Philips Parkway
Montvale, New Jersey 07645
---------------

PROXY STATEMENT

This Proxy Statement is furnished in connection with the solicitation
by the Board of Directors of Datascope Corp. (the "Corporation") of proxies to
be used at the Annual Meeting of Shareholders of the Corporation to be held at
11:00 o'clock a.m., local time, on December 7, 1999, at The Harmonie Club, 4
East 60th Street, New York, New York, and at any adjournments thereof. The
purposes of the meeting are:

1. To elect two directors of the Corporation to hold office until
the Annual Meeting of Shareholders and until the election and
qualification of their respective successors;

3. To transact such other business as may properly come before
the meeting.

If proxy cards in the accompanying form are properly executed and
returned, the shares of Common Stock represented thereby will be voted as
instructed on the proxy. If no instructions are given, such shares will be voted
(i) for the election as directors of the nominees of the Board of Directors
named below, (ii) for the proposal to amend the 1995 Stock Option Plan, and
(iii) in the discretion of the Proxies named in the proxy card on any other
proposals to properly come before the meeting or any adjournment thereof. Any
proxy may be revoked by a shareholder prior to its exercise upon written notice
to the Secretary of the Corporation, or by the vote of a shareholder cast in
person at the meeting. If a proxy is not returned, the shares represented by
such proxy will not be voted. The approximate date of mailing of this Proxy
Statement is November 1, 1999.

VOTING

Holders of record of the Corporation's Common Stock on October 27, 1999
will be entitled to vote at the Annual Meeting or any adjournment thereof. As of
that date, there were 14,982,206 shares of Common Stock outstanding and entitled
to vote. A majority of the outstanding Common Stock represented at the meeting
in person or by proxy will constitute a quorum for the transaction of business.
Abstentions and broker non-votes are counted for purposes of determining the
presence or absence of a quorum for the transaction of business; however,
unreturned proxies are not counted for purposes of determining the presence or
absence of a quorum. Each share of Common Stock entitles the holder thereof to
one vote on all matters to come before the meeting, including the election of
directors.

The favorable vote of a majority of the votes cast at the meeting is
necessary to elect each director of the Corporation. The favorable vote of a
majority of the votes cast at the meeting is necessary to amend the 1995 Stock
Option Plan. Abstentions, broker non-votes and shares represented by unreturned
proxies are not considered votes cast and will have no effect on the outcome of
the matters scheduled to be considered at the Annual Meeting. The Board of
Directors recommends a vote FOR each of the nominees named below and FOR the
proposal to amend the 1995 Stock Option Plan.

<PAGE>

ITEM 1. ELECTION OF DIRECTORS

Two (2) directors are to be elected at the Annual Meeting. The Board of
Directors has recommended the persons named in the table below as nominees for
election as directors. All such persons are presently directors of the
Corporation. Unless otherwise specified in the accompanying proxy, the shares
voted pursuant to it will be voted for the persons named below as nominees for
election as directors. If, for any reason, at the time of the election any of
the nominees should be unable or unwilling to accept election, it is intended
that such proxy will be voted for the election, in such nominee's place, of a
substitute nominee recommended by the Board of Directors. However, the Board of
Directors has no reason to believe that any nominee will be unable or unwilling
to serve as a director.

INFORMATION AS TO NOMINEES AND OTHER DIRECTORS

The following information is supplied with respect to the nominees for
election as directors of the Corporation in Class II, and for the directors in
Classes I and III whose terms expire at the Annual Meeting of Shareholders
occurring in 2001 and 2000, respectively, and until the election and
qualification of their respective successors. Unless otherwise indicated below,
each director has had the principal occupation(s) indicated on the table for
five years or more.

NOMINEES FOR DIRECTOR

CLASS II (If elected each director will hold office until the 2002
Annual Meeting of Shareholders.)

Class II

Principal Occupation Has Been a Director of
Name of Nominee Age or Employment the Corporation During
- --------------- --- -------------------- ----------------------
<S> <C> <C> <C>
David Altschiller 58 Chairman/Chief Executive Officer of 1982-present
Hill, Holliday & Altschiller(1)
Joseph Grayzel, M.D 68 Consultant to the Corporation and 1969-present
Physician

</TABLE>

- ----------

(1) Hill, Holliday & Altschiller is the New York office of Hill, Holliday,
Connors, Cosmopulos, Inc., a Boston advertising agency.

DIRECTORS WHOSE TERM OF OFFICE
WILL CONTINUE AFTER THE ANNUAL MEETING

Class I (Term expires at the 2001 Annual Meeting of Shareholders.)

<TABLE>
<CAPTION>
Principal Occupation Has Been a Director of
Name of Director Age or Employment the Corporation During
- --------------- --- -------------------- ----------------------
<S> <C> <C> <C>
George Heller 77 Director(2) 1970-1979
1980-present
William L. Asmundson 62 President and Chief Executive 1969-present
Officer of Rockefeller & Co., Inc.
</TABLE>

- ----------

(2) Mr. Heller also served as Senior Vice President of the Corporation from
1970 through 1979 and from 1980 through October 1992 and as Secretary
of the Corporation from 1970 through 1979 and from 1980 through
December 1992.

<PAGE>

Class III (Term expires at the 2000 Annual Meeting of Shareholders.)

Lawrence Saper 71 Chairman of the Board and Chief 1964-present
Executive Officer of the Corporation
Alan B. Abramson 53 Attorney(3) 1996-present
Arno Nash 72 Chairman of Iterman Industrial 1965-1967
Products Ltd.(4) 1996-present

</TABLE>

- ----------

(3) Mr. Abramson has served as President of Abramson Brothers Incorporated
since 1972.

(4) Mr. Nash has served as Chairman of Iterman Industrial Products Ltd.
since 1965.

MEETINGS OF THE BOARD

During the fiscal year ended June 30, 1999, five meetings of the Board
of Directors were held. Each of the directors attended 75% or more of the
aggregate number of meetings of the Board of Directors and committees on which
he served.

The Board of Directors has an audit committee consisting of Messrs.
Abramson, Asmundson and Nash. The primary functions of the committee are to
review the Corporation's financial statements, recommend the appointment of the
Corporation's independent auditors and review the overall scope of the audit.
This committee held two meetings during the Corporation's last fiscal year.

The Corporation has a stock bonus committee consisting of Dr. Grayzel
and Messrs. Saper and Heller. This committee is empowered to authorize the
issuance of shares of the Corporation's Common Stock to certain employees of the
Corporation or its subsidiaries who have provided outstanding services on behalf
of the Corporation. This committee did not hold any meetings during the
Corporation's last fiscal year.

The Board of Directors has a compensation committee (the "Compensation
Committee"), which consisted of Messrs. Abramson, Asmundson and Heller. The
primary responsibility of this committee is to administer and make
recommendations to the Board regarding the Corporation's bonus plans, to review
the compensation arrangements relating to officers who are members of the Board
of Directors and to administer the Datascope Corp. 1981 Incentive Stock Option
Plan and the Datascope Corp. 1995 Stock Option Plan. This committee held four
meetings during the Corporation's last fiscal year.

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), requires the Corporation's directors and executive officers and
persons who beneficially own more than 10% of a registered class of the
Corporation's equity securities ("Reporting Persons") to file reports of
ownership and changes in ownership with the Commission on a timely basis.
Reporting Persons are required to furnish the Corporation with copies of all
such forms that they file. Based solely on its review of such forms, except as
set forth in the remainder of this section, the Corporation believes that all
filing requirements applicable to Reporting Persons during and with respect to
fiscal 1999 were complied with on a timely basis.

The following individuals who were executive officers of the
Corporation during fiscal year 1999 acquired shares of Common Stock under the
Datascope Corp. 401(k) Savings and Supplemental Retirement Plan (the "401(k)
Plan") on a monthly basis and, under Section 16(a), a Form 4 was required to be
filed by each executive officer within

<PAGE>

ten days after the end of the month in which each acquisition occurred: Lawrence
Saper, Nicholas E. Barker and Stanton J. Rowe. Rather than filing a Form 4 in
respect of each acquisition of shares of Common Stock pursuant to the 401(k)
Plan to report such acquisition, each such executive officer filed a Form 5
required by Section 16(a) on August 6, 1999.

SECURITY OWNERSHIP OF CERTAIN SHAREHOLDERS

The following table provides information as to each person who is known
to the Corporation to be the beneficial owner of more than 5% of the
Corporation's voting securities as of October 1, 1999 (unless otherwise
indicated):

<TABLE>
<CAPTION>
Amount and Nature of Percent of
Name and Address of Beneficial Owner(1) Beneficial Ownership(1) Common Stock(2)
- --------------------------------------- ----------------------- ---------------
<S> <C> <C>

Lawrence Saper
14 Philips Parkway 3,044,288(3) 19.5%
Montvale, NJ 07645

Private Capital Management, Inc.
3003 Tamiami Trail N. 1,201,413(4) 8.0%
Naples, FL 34103

</TABLE>

- ----------

(1) This table identifies persons having sole voting and investment power
with respect to the shares set forth opposite their names as of October
1, 1999, except as otherwise disclosed in the footnotes to the table,
according to information publicly filed or furnished to the Corporation
by each of them.

(2) Shares beneficially owned, as recorded in this table, expressed as a
percentage of the shares of the Common Stock of the Corporation
outstanding as of October 1, 1999. For purposes of calculating Mr.
Saper's beneficial ownership, any shares issuable pursuant to options
exercisable within 60 days of October 1, 1999 are deemed to be
outstanding.

(3) Includes (i) 38,081 shares owned by trusts created by Mr. Saper for his
minor children, (ii) 3,150 shares owned by Carol Saper, Mr. Saper's
wife, (iii) 124,787 shares which are owned by an irrevocable trust of
which Carol Saper and Martin Nussbaum are trustees, and (iv) 45,000
shares donated to the Lawrence and Carol Saper Foundation, a
charitable foundation. Mr. Saper will receive annual distributions from
the trust equal to 55.5% of the trust's initial net fair market value
until November 2, 1999; thereafter, the sole beneficiaries are Carol
Saper and Mr. Saper's descendants. The trustees have the sole right to
vote and dispose of the shares. Mr. Saper disclaims beneficial
ownership of all of the foregoing shares.

(4) Private Capital Management, Inc. ("PCM") is an Investment Adviser
registered under Section 203 of the Investment Advisers Act of 1940, as
amended. As of October 1, 1999, PCM had shared dispositive power with
respect to 1,201,413 shares of Common Stock, sole voting power and sole
dispositive power with respect to 3,000 shares of common stock and did
not have shared voting power with respect to any shares of Common
Stock. The information set forth herein was obtained from information
furnished to the Corporation by PCM on October 1, 1999.

<PAGE>

SECURITY OWNERSHIP OF MANAGEMENT

The following table provides information as of October 1, 1999 with
respect to the Common Stock of the Corporation beneficially owned by each
director and nominee (except Mr. Saper, whose holdings are shown in the
preceding table) and each of the Named Executive Officers (as defined in
"Executive Compensation" below), other than Mr. Saper, and by all directors and
executive officers as a group (including Mr. Saper):

Amount and Nature Percent of
Name of Beneficial Owner(1) of Beneficial Ownership Common Stock(2)
- --------------------------- ----------------------- ---------------
Alan B. Abramson............... 5,000(3) *
David Altschiller.............. 15,650(4) *
William L. Asmundson........... 28,250(4) *
Joseph Grayzel, M.D............ 256,171(5) 1.7%
George Heller.................. 52,704(6) *
Arno Nash...................... 13,500(3) *
Murray Pitkowsky............... 71,489(7) *
John Gilbert................... 19,440(8) *
Stanton J. Rowe................ 21,637(9) *
S. Arieh Zak................... 31,625(10) *
All executive officers and
directors as a group (consisting
of 17 individuals)............. 3,642,529(11) 23.0%
- ----------

* Less than 1%.

(1) This table identifies persons having sole voting and investment power
with respect to the shares set forth opposite their names, except as
otherwise disclosed in the footnotes to the table, according to
information furnished to the Corporation by each of them.

(2) Shares beneficially owned, as recorded in this table, expressed as a
percentage of the shares of the Common Stock of the Corporation
outstanding as of October 1, 1999. For the purpose of calculating each
person's beneficial ownership, any shares issuable pursuant to options
exercisable within 60 days of October 1, 1999 are deemed to be
beneficially owned by, and outstanding with respect to, such person.

(3) Includes 5,000 shares which are issuable pursuant to currently
exercisable options.

(4) Includes 14,000 shares which are issuable pursuant to currently
exercisable options.

(5) Does not include 31,500 shares held in the name of Dr. Grayzel's
children (all of whom have attained majority) under the Uniform Gift to
Minors Act, as to which shares Dr. Grayzel disclaims beneficial
ownership. Includes 39,000 shares which are issuable pursuant to
currently exercisable options. Does not include 25,000 shares which are
issuable pursuant to options which will vest on the attainment of
certain milestones.

(6) Includes 8,000 shares which are issuable pursuant to currently
exercisable options.

(7) Includes 38,750 shares which are issuable pursuant to currently
exercisable options.

(8) Includes 17,025 shares which are issuable pursuant to currently
exercisable options.

(9) Includes 21,250 shares which are issuable pursuant to currently
exercisable options.

(10) Includes 31,625 shares which are issuable pursuant to currently
exercisable options.

(11) Includes 886,359 shares which are issuable pursuant to currently
exercisable options.

<PAGE>

EXECUTIVE OFFICERS OF THE CORPORATION

The following table sets forth the names, ages and all positions and
offices with the Corporation held by the Corporation's present executive
officers. Unless otherwise indicated below, each person has held the office
indicated for more than five years:

Name Age Positions and Offices Presently Held
- ---- --- ------------------------------------
<S> <C> <C>
Lawrence Saper.................. 71 Chairman of the Board and Chief Executive Officer
Murray Pitkowsky................ 68 Senior Vice President and Secretary (1)
Leonard S. Goodman ............. 55 Vice President, Treasurer and Chief Financial Officer(2)
Nicholas E. Barker.............. 41 Vice President, Design(3)
James L. Cooper................. 48 Vice President, Human Resources(4)
John Gilbert.................... 42 Vice President; President, Collagen Products Division(5)
Timothy J. Haines............... 42 Vice President; President, InterVascular, Inc.(6)
Stanton J. Rowe................. 48 Vice President, Business Development(7)
Donald Southard................. 53 Vice President; President, Patient Monitoring Division(8)
Paul J. Southworth.............. 55 Vice President, President Cardiac Assist(9)
S. Arieh Zak.................... 38 Vice President, Regulatory Affairs and Corporate Counsel(10)

</TABLE>

- ----------

(1) Mr. Pitkowsky has been employed by the Corporation as Senior Vice
President since October 1992, and as Secretary since January 1993. From
April 1986 through October 1992, Mr. Pitkowsky served as Vice
President, Finance and Treasurer of the Corporation. He served as
Treasurer from December 1996 to December 1997 and from February 1994 to
May 1994. Mr. Pitkowsky also served as Chief Financial Officer from
December 1996 to October 1998 and from August 1994 to May 1995. Mr.
Pitkowsky also served as acting President of Cardiac Assist from
September 1998 to June 1999.

(2) Mr. Goodman has been employed as Chief Financial Officer of the
Corporation since October 1998 and served as Treasurer since September
1999. Mr. Goodman served as President of LSG Associates, Financial and
Business Strategy Consulting from October 1997 to September 1998. Mr.
Goodman served as Senior Vice President and Chief Financial Officer at
Benjamin Moore & Co. from April 1997 to September 1997 and was Vice
President and Chief Financial Officer at Thompson Minwax Corporation
from June 1996 to January 1997. Mr. Goodman served as Vice President,
Finance and Chief Financial Officer at GAF Building Materials
Corporation from August 1989 to May 1996.

(3) Mr. Barker has been employed by the Corporation as Vice President,
Design since December 1997. Mr. Barker was employed by the Corporation
as Manager, Corporate Design from October 1993 to December 1997 and as
an Industrial Designer from September 1991 to October 1993.

(4) Mr. Cooper has been employed by the Corporation as Vice President,
Human Resources since January 1998. Mr. Cooper served as Vice
President, Human Resources of Schindler Elevator Corporation from
January 1994 to January 1998 and was Group Vice President, Human
Resources at Ingersoll-Rand Corporation from August 1988 to January
1994.

(5) Mr. Gilbert has been employed as a Vice President of the Corporation
and as the President of the Collagen Products Division since September
1997. Mr. Gilbert served as General Manager of the Collagen Products
Division from May 1997 to September 1997. Previously, he served as
Director of VasoSeal Sales for the Collagen Products Division from July
1995 to May 1997. Mr. Gilbert served as an Area Sales Director for the
Patient Monitoring Division, beginning in 1994. Prior to becoming Area
Sales Director, Mr. Gilbert served as a Regional Sales Manager and Zone
Manager for the Patient Monitoring Division. Mr. Gilbert has been
employed by the Corporation since 1983.

<PAGE>

(6) Mr. Haines has been employed as a Vice President of the Corporation and
as the President of InterVascular, Inc. since August 1998. Mr. Haines
served as Vice President, International Distribution and Markets of the
Corporation from August 1997 to August 1998. Mr. Haines was Vice
President, Managing Director, Europe at Heartport from March 1997 to
August 1997. Mr. Haines served as a Vice President of the Corporation
and as the President of the Patient Monitoring Division from July 1996
to March 1997. From July 1993 to June 1996, Mr. Haines served as the
President of InterVascular, Inc., a wholly owned subsidiary of the
Corporation. From June 1992 to July 1993, Mr. Haines served as Vice
President, Operations of Telectronics, Inc.

(7) Mr. Rowe has been employed by the Corporation as Vice President,
Business Development since September 1996. From September 1996 to
February 1997, Mr. Rowe also served as Acting President, Cardiac Assist
Division. Prior to his employment with the Corporation, Mr. Rowe served
as Vice President, New Business Development of Johnson & Johnson
Interventional Systems Company from January 1990 to July 1996.

(8) Mr. Southard has been employed as a Vice President of the Corporation
and as the President of the Patient Monitoring Division since February
1997. Mr. Southard served as Vice President, Sales of the Patient
Monitoring Division from July 1996 to February 1997. Prior to his
employment with the Corporation, Mr. Southard served as Vice President,
Sales and Marketing of Elscint, Inc. from August 1994 to June 1996, and
as Chief Executive Officer of Serviscope Corp. from November 1991 to
May 1994.

(9) Mr. Southworth has been employed as Vice President of the Corporation
and as President of the Cardiac Assist Division since June 1999. Prior
to his employment with the Corporation, Mr. Southworth served as
President of the Vascular Division - Research and Development/
Technical Operations of Boston Scientific Corporation from July 1998
to June 1999 and President of the Meadox Medicals Division of
Boston Scientific Corporation from February 1996 to July 1998. From
September 1995 to February 1996, Mr. Southworth served as President of
the Renal Products Group, National Medical Care Division of W. R.
Grace. Mr. Southworth served as Vice President of Worldwide Operations
of Davis and Geck Division of American Cyanamid from June 1990 to
February 1996.

(10) Mr. Zak has been employed by the Corporation as Corporate Counsel since
November 1992, and as Vice President of Regulatory Affairs since
September 1995. From 1986 through 1992 Mr. Zak served as a litigation
associate at Sullivan & Cromwell.

<PAGE>

EXECUTIVE COMPENSATION
Summary Compensation Table

The following table sets forth for the fiscal years ended June 30,
1999, 1998, and 1997, the compensation for services in all capacities to the
Corporation of those persons who were at June 30, 1999 the chief executive
officer and the other four most highly compensated executive officers of the
Corporation (collectively, the "Named Executives"):

<TABLE>
<CAPTION>
Long Term Compensation
----------------------
Annual Compensation Awards Payouts
------------------- ------ -------
Other Restricted
Annual Stock LTIP All Other
Name and Salary Bonus Compensation Awards Options Payouts Compensation
Principal Position Year ($) ($) ($) ($) (#) ($) ($)(1)
------------------ ---- ------ ----- ------------ ---------- ------- ------- ------------
<S> <C> <C> <C> <C> <C> <C> <C> <C>

Lawrence Saper.................. 1999 887,662 771,300 267,381(2) -- 70,000 -- 12,849
Chairman of the Board and 1998 850,650 638,000 249,014(2) -- -- -- 11,339
Chief Executive Officer 1997 795,000 600,000 224,412(2) -- -- -- 9,869

Murray Pitkowsky,............... 1999 215,000 75,000 -- -- 10,000 -- 10,185
Senior Vice President and 1998 215,000 75,000 -- -- 10,000 -- 8,176
Secretary 1997 215,000 75,000 -- -- 15,000 -- 6,989

Stanton J. Rowe................. 1999 207,500 63,000 -- -- 15,000 -- 5,924
Vice President, 1998 197,500 60,000 -- -- 20,000 -- 7,893
Business Development 1997 154,071 60,000 86,328(3) -- 25,000 -- 822

John Gilbert.................... 1999 186,250 80,000 -- -- 15,000 -- 5,894
Vice President; 1998 171,250 76,000 -- -- 7,500 -- 6,475
President, Collagen Products 1997 130,000 84,000 -- -- 14,000 -- 5,139

S. Arieh Zak.................... 1999 201,000 55,000 -- -- 6,500 -- 5,921
Vice President, Regulatory 1998 192,500 51,000 59,168(4) -- 7,500 -- 5,082
Affairs and Corporate Counsel 1997 182,500 122,500(5) -- -- 15,000 -- 5,960

</TABLE>

- ----------
(1) Amounts in this column represent (a) Corporation matching contributions
under the Corporation's 401(k) Plan, (b) premiums for term life
insurance and (c) with respect to split dollar life insurance policies
maintained by the Corporation for the benefit of Messrs. Saper and
Pitkowsky, the actuarial value of the benefit to such Named Executives
of the current year's insurance premium paid by the Corporation in
excess of that required to fund the death benefit under the policy. The
amounts comprising items (a), (b) and (c) described above for each
Named Executive in fiscal year 1997 are as follows: Saper: (a) $4,750,
(b) $1,124 and (c) $3,995; Pitkowsky: (a) $4,750, (b) $732 and (c)
$1,507; Rowe: (a) $0 and (b) $822; Gilbert: (a) $4,225 and (b) $914;
and Zak: (a) $4,875 and (b) $1,085. The amounts comprising items (a),
(b) and (c) described above for each Named Executive in fiscal year
1998 are as follows: Saper (a) $4,800, (b) $1,124 and (c) $5,415;
Pitkowsky (a) $4,750, (b) $996 and (c) $2,430; Rowe: (a) $6,775 and (b)
$1,118; Gilbert: (a) $5,425 and (b) $1,050; and Zak: (a) $3,978 and (b)
$1,104. The amounts comprising items (a), (b) and (c) described above
for each Names Executive in fiscal year 1999 are as follows: Saper (a)
$4,800, (b) $1,124, and (c) $6,925; Pitkowsky (a) $4,800, (b) $878, and
(c) $4,507; Rowe (a) $4,800, (b) $1,124; Gilbert: (a) $4,800 and (b)
$1,094; and Zak: (a) $4,800 and (b) $1,121. Cumulative net life
insurance premiums paid under the split dollar life insurance program
are recoverable (i) with respect to Mr. Saper, on death, if not
recovered earlier, and (ii) with respect to Mr. Pitkowsky, at
retirement or death.

(2) Includes payments for automobile and reimbursement for executive
portion of split dollar life insurance, respectively, in the following
amounts: $70,490 and $145,115 in fiscal 1999; $69,290 and $131,970 in
fiscal 1998; and $66,297 and $112,470 in fiscal 1997.

<PAGE>

(3) Includes $85,619 reimbursement for relocation expenses.

(4) Includes $43,242 reimbursement for medical expenses and $15,926
representing personal use of automobile leased by the Corporation.

(5) Includes special incentive award of $95,000 granted in May 1995 for
which payment of $47,500 was made in fiscal 1996 and $47,500 was paid
in fiscal 1997.

Options Of Named Executives To Purchase Securities

On October 1, 1981, the Corporation adopted the 1981 Stock Option Plan,
which was subsequently approved by the shareholders at the 1981 Annual Meeting.
Options that qualify as, and options that do not qualify as, incentive stock
options under the Internal Revenue Code of 1986, as amended (the "Code"), may be
granted thereunder. The 1981 Stock Option Plan, as amended, reserved 3,075,000
shares of Common Stock for issuance to key employees and officers recommended
and approved by the Board of Directors, or a committee thereof, at a price not
less than 100% (or, in the case of an incentive stock option granted to a 10%
shareholder, 110%) of the fair market value of the shares purchased thereunder
on the date of grant. No option may be exercisable more than ten years from the
date of grant, and an incentive stock option granted to a 10% shareholder may
not be exercisable more than five years from the date of grant. The Stock Option
Plan is administered by the Compensation Committee. The 1981 Stock Option Plan
terminated on September 30, 1996; but options issued thereunder remain
outstanding. Consequently, the Corporation can no longer issue options under the
1981 Stock Option Plan.

On September 19, 1995, the Corporation adopted the 1995 Stock Option
Plan, which was subsequently approved by the shareholders at the 1995 Annual
Meeting. Options that qualify as, and options that do not qualify as, incentive
stock options under the Code may be granted thereunder. The 1995 Stock Option
Plan reserved 750,000 shares of Common Stock for issuance to key employees and
officers recommended and approved by the Board of Directors, or a committee
thereof, at a price not less than 100% (or, in the case of an incentive stock
option granted to a 10% shareholder, 110%) of the fair market value of the
shares purchased thereunder on the date of grant. No option may be exercisable
more than ten years from the date of grant, and an incentive stock option
granted to a 10% shareholder may not be exercisable more than five years from
the date of grant. The Stock Option Plan is administered by the Compensation
Committee. The 1995 Stock Option Plan terminates on September 17, 2005. On
December 9, 1997, Shareholders adopted an Amendment to the 1995 Stock Option
Plan which increased to 1,500,000 the number of shares of the Corporation's
Common Stock which may be the subject of options granted pursuant to the 1995
Stock Option Plan. The Board of Directors has recommended an increase in the
aggregate number of shares of Common Stock for issuance under the 1995 Stock
Option Plan from 1,500,000 to 2,750,000.

Option Grants in Last Fiscal Year

Individual Grants
-------------------------- Potential Realized
Number of % of Total Value at Assumed Annual
Securities Options Rates of Stock Price
Underlying Granted to Appreciation for Option Term
Options Employees in Exercise Price Expiration ----------------------------
Name Granted(#) Fiscal Year ($/sh) Date 5%($) 10%($)
- ---- ---------- ------------ -------------- ---------- ----- ------
<S> <C> <C> <C> <C> <C> <C>
Lawrence Saper 70,000(1) 15.5 26.938 May 25, 2009 1,185,470 3,003,979
Murray Pitkowsky 10,000(2) 2.2 26.938 May 25, 2009 169,353 429,140
Stanton J. Rowe 15,000(2) 3.3 26.938 May 25, 2009 254,029 643,710
John Gilbert 15,000(2) 3.3 26.938 May 25, 2009 254,029 643,710
S. Arieh Zak 6,500(2) 1.4 26.938 May 25, 2009 110,079 278,941

</TABLE>

(1) The option became fully exercisable on date of grant, May 26, 1999.

(2) The option becomes exercisable in four equal annual installments
beginning on May 26, 2000. However, prior to May 26, 2004 the portion
of the option is exercisable only if the average of the high and low
sales prices of the Common Stock as quoted on The NASDAQ National
Market System on the trading day immediately preceding the exercise
date is equal to or greater than $33.75. After May 26, 2004, the option
is fully exercisable, without regard to the price of the Common Stock.

- ----------

<PAGE>

Aggregated Option Exercises in Last Fiscal Year and Fiscal Year-End Option
Values

<TABLE>
<CAPTION>
Number of Securities
Shares Underlying Unexercised Value of Unexercised In-the-
Acquired Value Options at Fiscal Year Money Options at Fiscal
on Exercise Realized End(#) Exercisable/ Year End($) Exercisable/
Name (#) ($) Unexercisable Unexercisable
- ---- --- --- -------------- --------------
<S> <C> <C> <C> <C>

Lawrence Saper 0 0 615,000/0 9,326,215/0
Murray Pitkowsky 7,500 120,788 32,500/27,500 365,312/228,428
Stanton J. Rowe 2,500 39,063 15,000/42,500 180,310/347,485
John Gilbert 2,250 34,126 15,650/28,000 188,224/195,066
S. Arieh Zak 10,000 121,410 27,875/22,125 308,171/201,032

</TABLE>

Pension Plan and Supplemental Benefit Plans

Pension Plan

The Corporation maintains the Datascope Corp. Pension Plan. Each year
the Corporation contributes an amount necessary to fund the plan on an actuarial
basis. Pension benefits to be received upon retirement are determined by an
employee's highest 5 consecutive years' earnings (based on base salary,
commission and certain bonus compensation paid to sales and service
representatives) in the 10 years preceding retirement, length of service with
the Corporation and age at retirement. Mr. Saper is currently credited with 35
years of service under the plan, Mr. Pitkowsky with 13 years, Mr. Rowe with 3
years, Mr. Gilbert with 16 years and Mr. Zak with 7 years. Pensions are reduced
by 1.5% of an employee's estimated primary Social Security benefit for each year
of credited service (to a maximum of 33 1/3 years). The net pension is limited
as required by the Employee Retirement Income Security Act of 1974, as amended
("ERISA"). The table below illustrates annual pension benefits on a single life
basis, assuming retirement at age 65 and prior to reduction for Social Security
benefits or application of the ERISA limits.

Pension Plan Table

Years of Service
-----------------------------------------------------
Final Average
Compensation 15 20 25 30 35
- ------------ -- -- -- -- --
$125,000 $28,125 $37,500 $46,875 $56,250 $65,625
150,000 33,750 45,000 56,250 67,500 78,750
175,000 39,375 52,500 65,625 78,750 91,875
200,000 45,000 60,000 75,000 90,000 105,000
225,000 50,625 67,500 84,375 101,250 118,125
250,000 56,250 75,000 93,750 112,500 131,250
300,000 67,500 90,000 112,500 135,000 157,500
400,000 90,000 120,000 150,000 180,000 210,000
450,000 101,250 135,000 168,750 202,500 236,250
500,000 112,500 150,000 187,500 225,000 262,500

Supplemental Benefit Plans

The Corporation also maintains certain plans which provide for
supplemental pension benefits for Messrs. Saper and Pitkowsky (the "Supplemental
Benefits Plans"). Under the terms of the plan maintained for Mr. Pitkowsky, he
is entitled to receive upon retirement a total annual benefit of $120,000, which
is payable for 15 years. The payments to be received were determined based upon
Mr. Pitkowsky's employment by the Corporation past age 65. The plan in effect
for Mr. Pitkowsky also provides for survivor benefits, including monthly
payments upon death. The plan in effect for Mr. Saper during fiscal year 1999
provides that upon his retirement, Mr. Saper is entitled to receive annual
lifetime payments, the amounts of which will be based on 60% of the average
total compensation for the three years in which Mr. Saper's compensation was
greatest of the ten years immediately preceding Mr. Saper's retirement, less the
benefit payable under the Datascope Corp. Pension Plan. However, the
supplemental retirement benefit will not be less than the value of the benefit
that would have been payable had Mr. Saper's retirement occurred at age 65,
which amount is actuarially increased to his actual retirement date. At June 30,
1999, the estimated annual benefit payable to Mr. Saper

<PAGE>

under his Supplemental Benefits Plan approximates $1,290,400. Under the terms of
Mr. Saper's Supplemental Benefits Plan, the annual benefit will be increased to
reflect changes in his compensation to retirement. The plan in effect for Mr.
Saper provides survivor benefits in the form of a $10,000,000 life insurance
policy, maintained pursuant to a split-dollar agreement among Mr. Saper, the
Corporation, and a trust for the benefit of Mr. Saper's family (the "Trust").
The Corporation's net investment in the program is recoverable on Mr. Saper's
death, but may be repaid sooner by the Trust. Benefits under each Supplemental
Benefits Plan are paid from the general funds of the Corporation; however, the
Corporation purchases key-man insurance intended to recover a substantial
portion of the net after-tax cost of the benefits.

Compensation of Directors and other Matters

The annual retainer for each director of the Corporation (except Mr.
Saper and Dr. Grayzel) (the "Non-Employee Directors") is $24,000, which is
payable in shares of the Corporation's Common Stock pursuant to the Datascope
Corp. Non-Employee Director Compensation Plan (the "Non-Employee Director
Plan"). Payment of the annual retainer will generally occur at the beginning of
the next succeeding calendar year. In connection with the payment of annual
retainers, the Corporation has reserved 25,000 shares of Common Stock for
issuance. A director may elect to defer receipt of compensation, in which case
the annual retainer will be paid entirely in shares of Common Stock. In the case
of directors electing current receipt of compensation, 40% of such portion is
paid in cash (to approximate current federal income tax liability) and the
balance in Common Stock. Effective September 1, 1998, Mr. Altschiller entered
into a consulting arrangement with the Corporation (which is described below)
and, as a result, is no longer eligible to participate in the Non-Employee
Director Plan.

From time to time, the Corporation has granted options to directors to
purchase shares of Common Stock. These options remain exercisable in full until
the earlier of ten years after the date of grant or the termination of status as
a director of the Corporation, and are not transferable except that each of the
options may be exercised by an executor or administrator within one year after
an optionee's death or disability but not beyond the option's normal expiration
date. Each option provides that the optionee may pay for any shares acquired
pursuant to the exercise of such option by cash or check or by transfer to the
Corporation of a number of shares of the Corporation's Common Stock with an
aggregate market value equal to the aggregate option exercise price. Such
options do not qualify as incentive stock options under the Code. For federal
income tax purposes, an optionee will realize taxable income on the date of
exercise of an option, and the Corporation will then be allowed a deduction from
income, equal to the excess of (a) the aggregate market value, on the date of
exercise, of the shares so acquired over (b) the aggregate option exercise price
for such shares.

Transactions with respect to stock options granted to directors who are
officers of the Corporation pursuant to the 1981 Stock Option Plan and the 1995
Stock Option Plan and with respect to the certain director options which have
been approved by the Corporation's shareholders are exempt from the short-swing
trading liability provisions of Section 16(b) of the Exchange Act, pursuant to
Rule 16b-3 of the Exchange Act. The 1981 Stock Option Plan and the 1995 Stock
Option Plan do not cover grants to directors who are not employees or officers
of the Corporation.

Director David Altschiller has been engaged as a consultant to the
Corporation since September 1998, providing advice and counsel in the area of
advertising. Pursuant to an oral agreement, from September 1998 through November
1998, the Corporation paid Mr. Altschiller a consulting annual retainer at the
annual rate of $100,000, payable on the first day of each month. Effective
December 1, 1998, Mr. Altschiller's annual retainer was increased to $134,500.
In addition, Mr. Altschiller was paid a discretionary bonus of $25,000 in August
1999 in respect of fiscal 1999.

Director Joseph Grayzel, M.D. has been engaged as a consultant to the
Corporation since January 1968. Pursuant to an oral agreement, Dr. Grayzel
spends approximately 30 hours per week providing advice and counsel to the
Corporation in the area of new product development. In consideration for these
services, the Corporation paid Dr. Grayzel a consulting fee totaling $161,700
during fiscal 1999. In addition, during fiscal 1999, Dr. Grayzel was paid a
discretionary bonus of $30,000 in respect of fiscal 1998.

Employment Contracts and Termination of Employment and Change in Control
Arrangements

The Corporation has entered into an employment agreement with Mr.
Saper, dated as of July 1, 1996. The agreement is for a term of five years with
automatic one-year extensions of the term of the agreement after July 1, 1997
unless either party gives notice of intent not to extend one hundred and eighty
days before any extension. The employment agreement provides for an annual base
salary and increases to the base salary as determined by the Board of Directors
or its Compensation Committee. On September 22, 1999, the Board determined to
increase Mr. Saper's annual base salary to $1,000,000. Pursuant to the terms of
the employment agreement, Mr. Saper is entitled to an annual bonus based on
criteria determined by the Compensation Committee. Under the employment
agreement, Mr. Saper is also entitled to receive bonus compensation in
accordance with any long-term and annual incentive compensation plans that are
maintained by the Corporation for the benefit of its executives, and to
participate in any other bonus plans maintained by the Corporation for its
executives. See "Compensation Committee Report on Executive Compensation." Mr.
Saper is also entitled to certain retirement benefits. See "Pension Plan and
Supplemental Benefit Plans." Mr. Saper may terminate the employment agreement
for good reason, including a significant breach by the Corporation of its

<PAGE>

obligations thereunder or certain changes-in-control of the Corporation, in
which event Mr. Saper is entitled to receive a lump-sum payment equal to his
compensation as then in effect (including base salary and prior year's bonus
compensation) multiplied by the number of years (including any partial years)
remaining in his term of employment.

The Corporation has agreed that in the event of a change in control of
the Corporation Messrs. Pitkowsky, Goodman and Southworth would each be entitled
to a lump-sum payment of 2.5 times such employee's annual base salary then in
effect.

COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION

The Compensation Committee establishes and reviews the Corporation's
arrangements and programs for compensating executive officers, including the
Named Executives. The Compensation Committee is composed entirely of directors
who are neither officers nor employees of the Corporation. The Compensation
Committee has been advised by outside legal counsel and by compensation
consultants in formulating the Compensation Committee's overall philosophy and
objectives regarding executive compensation and in structuring the Chief
Executive Officer's compensation package.

Philosophy and Policy

The Compensation Committee's policy is to design executive compensation
packages that reward the achievement of both short-term and long-term objectives
of the Corporation. Under this approach, the attainment of yearly earnings and
other short-term targets is compensated through yearly bonuses under the bonus
plans described below, and long-term performance of the Corporation is rewarded
through the grant of stock options under the 1995 Stock Option Plan described
above. The bonuses and stock options are in addition to executives' yearly base
salaries, which are determined in a manner to be competitive with companies
which the Compensation Committee believes are comparable to the Corporation in
the Corporation's industry.

The Datascope Corp. Annual Incentive Plan (the "Annual Incentive
Plan"), approved by the Shareholders in 1997, allows for annual bonus payments
to eligible executives based on attainment of overall corporate and division
financial thresholds and targets and certain subjective criteria; in the case of
Mr. Saper, the thresholds and targets are limited to objective financial
criteria. The thresholds and targets are established annually by the
Corporation's Board of Directors. Bonuses are granted to participants if the
thresholds are achieved, and the size of the executive's bonus increases with
the level of achievement up to a certain maximum level of bonus. However, the
Compensation Committee has the discretion to (i) decrease or eliminate the award
payable to any executive who is covered by Section 162(m) of the Code (such as
Mr. Saper) (each a "Covered Employee"), or (ii) increase, decrease or eliminate
the award payable to any other executive, to reflect the individual performance
and contribution of, and other factors relating to, such executive.

The Compensation Committee believes that, in addition to compensating
executives for the long-term performance of the Corporation, the grant of stock
options aligns the interest of the executives with those of the Corporation's
shareholders. The Compensation Committee determines the recipients of stock
option grants and the size of the grants consistent with these principles, and
based on the employee's performance and position with the Corporation.

Compensation of the Chief Executive Officer

Mr. Saper's compensation for fiscal year 1999 was determined by an
employment agreement entered into as of July 1996. The overall compensation
included in the agreement was determined in a manner to be competitive with
companies which the Compensation Committee believes are comparable to the
Corporation in the Corporation's industry. Under the Annual Incentive Plan, Mr.
Saper's total bonus compensation was $771,300 for fiscal year 1999.

Deductibility of Executive Compensation

Section 162(m) of the Code generally disallows a tax deduction for
compensation over $1,000,000 paid to the Corporation's Chief Executive Officer
and certain other highly compensated executive officers. Qualifying
performance-based compensation will not be subject to the deduction limit if
certain requirements are met. Because the Annual Incentive Plan received
Shareholder approval in 1997, amounts payable to Mr. Saper and other Covered
Employees under the Annual Incentive Plan can be deducted under Section 162(m)
of the Code.

<PAGE>

Compensation Committee

Alan B. Abramson
William L. Asmundson
George Heller

The foregoing report of the Compensation Committee shall not be deemed
incorporated by reference by any general statement incorporating by reference
the Proxy Statement into any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except to the extent that the Corporation
specifically incorporated this information by reference and shall not otherwise
be deemed filed under such Acts.

Performance Graph

The following graph compares the cumulative total shareholder return on
Common Stock with the cumulative total return of the Standard & Poor's 500 Stock
Index and the Standard & Poor's Medical Products and Supplies Index for the five
year period commencing July 1, 1994 and each subsequent June 30 through June 30,
1999. The graph assumes that the value of the investment in Common Stock was
$100 on July 1, 1994 and that all dividends were reinvested.

S & P MEDICAL
Measurement Period PRODUCTS
(Fiscal Year Covered) DATASCOPE CORP. S & P 500 & SUPPLIES
--------------------- --------------- ----------- -----------
1994 100 100 100
1995 107.81 126.07 153.42
1996 110.94 158.86 201.56
1997 122.66 213.98 267.09
1998 166.02 278.52 357.28
1999 200.78 341.90 424.99

ITEM 2. APPROVAL OF AMENDMENT TO THE 1995 STOCK OPTION PLAN

As of October 1, 1999, there were 32,085 shares of authorized Common
Stock which are available for granting new options (each an "Option") issued
under the 1995 Stock Option Plan. The Board of Directors of the Corporation
believes that the authorization of additional shares of Common Stock that may be
issued pursuant to Options granted to officers and key employees under the 1995
Stock Option Plan would assist the Corporation in attracting and retaining
qualified employees. Accordingly, the Board of Directors approved an amendment
to the 1995 Stock Option Plan that would increase the aggregate number of shares
of Common Stock which may be the subject of Options granted pursuant to the 1995
Stock Option Plan from 1,500,000 to 2,750,000 shares. If the amendment to the
1995 Stock Option Plan is not approved, no additional Options would be granted
under the 1995 Stock Option Plan after the options initially authorized are
granted. The increased number of shares of Common Stock subject to the 1995
Stock Option Plan would constitute approximately 8% of the shares of Common
Stock that were outstanding, and reserved for issuance pursuant to outstanding
Options, as of October 1, 1999.

Stock Option Plan

The following is a summary of the material provisions of the 1995 Stock
Option Plan. Such summary should, however, be read in conjunction with, and is
qualified in its entirety by the complete text of the 1995 Stock Option Plan, as
proposed to be amended, as set forth in Exhibit A to this Proxy Statement and
incorporated herein by reference.

General Information. The 1995 Stock Option Plan currently provides for
the issuance of Options to purchase up to 2,750,000 shares of Common Stock. Each
Option may be either an Incentive Stock Option ("ISO") as defined in Section 422
of the Code or a Non-Qualified Stock Option ("NQSO"). The 1995 Stock Option Plan
is designed to aid the Corporation and its subsidiaries in retaining and
attracting personnel of exceptional ability by enabling key employees to
purchase a proprietary interest in the Corporation, thereby stimulating in such
individual an increased desire to render greater services which will contribute
to the continued growth and success of the Corporation and its subsidiaries.
Officers and key employees (approximately 200 persons) are currently eligible
for grants of Options under the 1995 Stock Option Plan. Any one participant may
be granted Options to purchase a maximum of 150,000 shares of Common Stock in
any one year (subject to adjustment as described below). Generally, any Option
granted under the 1995 Stock Option Plan which is forfeited, expires or
terminates prior to vesting or exercise will again be available for award under
the 1995 Stock Option Plan; provided, however, that in the case of a
cancellation or termination of an Option in the same fiscal year that such
Option was granted (or for purposes of determining the maximum number of Options
which may be granted to a participant under the Plan, the cancellation or
termination of an Option at any time), both the canceled

<PAGE>

Option and the newly granted Option shall be counted in determining whether the
participant has received the maximum number of Options permitted to be issued to
any one participant under the Plan.

Term. The 1995 Stock Option Plan will terminate on September 17, 2005,
unless the Board of Directors, in its sole discretion, terminates the 1995 Stock
Option Plan prior to that date.

Outstanding Options Subject to the Plan. As of October 1, 1999, Options
granted to purchase an aggregate of 1,312,116 shares of Common Stock (with per
share exercise prices ranging from $16.50 to $35.00 and expiration dates ranging
from September 2005 to September 2009) were outstanding under the 1995 Stock
Option Plan. On October 1, 1999, the closing price of the Common Stock was
$37.81 per share.

Plan Administration. The Compensation Committee or other duly
designated committee of the Board shall administer the 1995 Stock Option Plan.
The Compensation Committee has the full authority to interpret the 1995 Stock
Option Plan, to establish and amend rules and regulations relating to it, to
determine the key employees to whom Options may be granted under the 1995 Stock
Option Plan, to select from among the eligible individuals those to whom Options
are to be granted, to determine the terms and provisions of the respective
Option agreements, and to make all other determinations necessary or advisable
for the administration of the 1995 Stock Option Plan. Members of the
Compensation Committee are not eligible to receive Options under the 1995 Stock
Option Plan; each member of the Compensation Committee is both a "disinterested
person" within the meaning of Rule 16b-3 under the Exchange Act and an "outside
director" as that term is defined for the purposes of Section 162(m) of the
Code.

The Stock Option Plan may be wholly or partially amended or otherwise
modified, or suspended at any time or from time to time by the Compensation
Committee, with the approval of the Board of Directors. However, the following
amendments can only be adopted subject to approval of the shareholders of the
Corporation: any amendment which (i) increases the number of Shares that may be
the subject of Options granted under the 1995 Stock Option Plan, (ii) expands
that class of individuals eligible to receive Options under the 1995 Stock
Option Plan, (iii) increases the period during which Options may be granted or
the permissible term of Options under the 1995 Stock Option Plan, (iv) decreases
the minimum exercise price of such Options, or (v) would require the approval of
Shareholders in order for options granted under the 1995 Stock Option Plan to
satisfy the requirements for performance-based compensation for purposes of
Section 162(m) (4) (C) of the Code (or successor provisions).

Neither the amendment, suspension nor termination of the 1995 Stock
Option Plan shall, without the consent of the holder of such Option, alter or
impair any rights or obligations under any Option theretofore granted.

Options Issued Under 1995 Stock Option Plan. The terms of specific
Options are determined by the Compensation Committee. The per share exercise
price of the Common Stock subject to Options shall not be less than 100% of the
fair market value of the shares of Common Stock on the date of grant. However,
in the case of ISOs granted to a holder of shares representing at least 10% of
the total combined voting power of the Corporation, or of any subsidiary or
parent thereof (a "10% Shareholder"), the per share exercise price shall not be
less than 110% of the fair market value of the Common Stock on the date of the
grant. Each Option will be exercisable during the period or periods specified by
the Compensation Committee, and set forth in an option agreement, which period
or periods shall not exceed 10 years from the date of grant, or five years, in
the case of ISOs granted to a 10% Shareholder. The aggregate fair market value,
determined as of the date of grant, of the Common Stock subject to ISOs which
may first become exercisable by an individual (under the 1995 Stock Option Plan
or any other plan of any parent or subsidiary of the Corporation) in any
calendar year shall not exceed $100,000. All shares available for issuance under
the 1995 Stock Option Plan may be ISOs.

The 1995 Stock Option Plan provides that the Compensation Committee
shall make adjustments with respect to the unexercised portion of any Option to
prevent the inequitable dilution or enlargement of the rights of any holder of
an Option. In the event of a merger or consolidation where the Corporation is
not the surviving corporation, and the agreements governing such transaction do
not provide for the substitution of new options in lieu of Options, the holder
of any Option granted under the 1995 Stock Option Plan will have the right, not
less than five days prior to the record date for the determination of
Shareholders entitled to participate in such merger or consolidation, to
exercise the total unexercised portion of his or her Option without regard to
any installment provisions of such Option, provided that all conditions
precedent to the exercise of such Option, other than the passage of time, have
been satisfied.

Upon the exercise of an Option, the holder of such Option shall pay the
Corporation the exercise price plus the amount of the required federal and state
withholding taxes, if any. The 1995 Stock Option Plan allows the participant to
pay the exercise price in cash or previously owned shares of Common Stock,
(which have been held by the option holder for at least 6 months prior to the
date the shares are surrendered for payment), or a combination thereof. The 1995
Stock Option Plan also allows participants to elect to have shares withheld upon
exercise for the payment of withholding taxes.

Should any employee terminate, either voluntarily or involuntarily, his
or her employment at the Corporation or any of its subsidiaries, while holding
any outstanding Options granted under the 1995 Stock Option Plan, such

<PAGE>

Options will terminate on the date of such termination of employment, regardless
of the term of the Option. However, if the termination of employment is due to
retirement, the holder may exercise any Option which the holder could have
exercised on the date of such termination of employment, provided that such
exercise is within the Option term and within three months of such termination
of employment. In addition, if the termination of employment is due to either
death or disability of the holder, the holder may exercise any Option which the
holder could have exercised on the date of such termination of employment,
provided that such exercise is within the Option term and within one year of
such termination of employment.

An employee exercising an Option is not permitted to sell or transfer
any Common Stock acquired thereby within seven months following the date of such
exercise without the prior written consent of the Corporation. In the event that
during the first six months of such period the holder of the Option ceases to be
an employee of the Corporation or its subsidiaries for any reason (other than
death), then the Corporation shall have the right for the duration of such seven
month period to repurchase all such shares of Common Stock which are subject to
such restriction at a purchase price equal to the aggregate exercise price paid
by the employee for such shares of Common Stock. The Compensation Committee has
waived this restriction on a per-employee basis for up to 2,500 exercisable
Options per calendar year from each Option grant.

New Plan Benefits. As of the date of this Proxy Statement, no Options
have been granted under the 1995 Stock Option Plan with respect to any shares of
Common Stock which are the subject of the proposed amendment to the 1995 Stock
Option Plan.

Federal Income Tax Consequences

Set forth below is a description of the federal income tax consequences
under the Code of the grant and exercise of options awarded under the 1995 Stock
Option Plan. This description does not purport to be a complete description of
the federal income tax aspects of the 1995 Stock Option Plan. The summary does
not include any discussion of state, local or foreign income tax consequences or
the effect of gift, estate or inheritance taxes, any of which may be significant
to a particular employee eligible to receive Options.

There will be no federal income tax consequences to employees or the
Corporation on the grant of a NQSO. On the exercise of a NQSO, the employee
generally will have taxable ordinary income, subject to withholding, equal to
the excess of the fair market value of the shares of Common Stock received on
the exercise date over the option price of the shares. The Corporation will be
entitled to a tax deduction for its taxable year in which the employee includes
the income, and in an amount equal to the amount of income recognized by the
employee provided the Corporation complies with applicable withholding and/or
reporting rules. Any ordinary income realized by an employee upon exercise of a
NQSO will increase his tax basis in the Common Stock thereby acquired.

With respect to Common Stock acquired upon the exercise of a NQSO which
will not be transferable for the first seven months after exercise without the
written consent of the Compensation Committee, and which will be subject to
repurchase by the Corporation at the option exercise price should the
participant cease to be an officer or employee of the Corporation or its
subsidiaries during the first six months of such seven month period, for federal
income tax purposes the Common Stock will be subject to a "substantial risk of
forfeiture" during such six month period. Thus, a participant will defer the
recognition of income until the end of that six month period (or until such
restriction is terminated) and recognize compensation income equal to the
difference between the exercise price and the market value of the Common Stock
at such time unless the participant elects to recognize compensation income on
the exercise date. Any additional gain or any loss recognized upon the
subsequent disposition of the acquired Common Stock will be a capital gain or
loss.

With respect to ISOs, no compensation income is recognized by an
employee, and no deduction is available to the Corporation upon either the grant
or exercise of an ISO, provided that, with respect to the exercise of an ISO,
(i) the optionee does not dispose of the shares of Common Stock acquired upon
such exercise (x) within two years after the date on which the ISO is granted or
(y) within one year after the date on which such shares are transferred to him,
and (ii) the optionee is an employee of the Corporation at all times during the
period which begins on the date on which the ISO is granted, and which ends
three months before the date of exercise. However, the difference between the
exercise price of an ISO and the market price of the Common Stock acquired on
the date that the substantial risk of forfeiture of the underlying Common Stock
lapses will be included in alternative minimum taxable income of a participant
for the purposes of the "alternative minimum tax." Generally, if an optionee
holds the shares acquired upon exercise of ISOs for the foregoing 2-year and
1-year periods, any gain recognized by the participant on a sale of such shares
will be treated as capital gain. The gain recognized upon the sale is the
difference between the option price and the sale price of the Common Stock.
Thus, the net federal income tax effects on the holder of ISOs generally is to
defer, until the shares are sold, taxation (other than for alternative minimum
tax purposes) of any increase in the value of the Common Stock from the time of
exercise to the time of sale, and to treat such gain as capital gain. If the
optionee sells the shares prior to the expiration of either holding period set
forth above (a "disqualified disposition"), the optionee will realize ordinary
compensation income in the amount equal to the difference between the exercise
price and the fair market value on the date that the substantial risk of
forfeiture of the underlying Common Stock lapses. The Corporation will be
entitled to

<PAGE>

take a deduction equal to the amount of the ordinary income which the optionee
realizes. The ordinary income is taken into account by the optionee, and the
deduction may be taken by the corporation, in the year of the disposition. The
compensation income will be added to the optionee's basis for purposes of
determining the gain on the sale of the shares. Such gain will be capital gain
if the shares are held as capital assets. If the amount realized on the sale is
less than the optionee's adjusted basis the compensation income required to be
recognized thereby, and the corresponding deduction allowed to the Corporation,
would be limited to the excess, if any, of the amount realized on the sale over
the exercise price.

An employee who surrenders shares of Common Stock in payment of the
exercise price of an Option will not recognize gain or loss on his or her
surrender of such shares, but, in the case of an NQSO, will recognize ordinary
income, as compensation, on the exercise of an NQSO as described below. Of the
shares received in such an exchange, that number of shares equal to the number
of shares surrendered will have the same tax basis and capital gains holding
period as the shares surrendered. The balance of the shares received will have a
tax basis equal , in general, to their fair market value on the date of exercise
in the case of an NQSO, and zero in the case of ISO, and the capital gains
holding period will begin on the date of exercise. The use by an employee of
shares of Common Stock previously acquired pursuant to the exercise of an ISO
will be treated as a taxable disposition if the transferred shares have not been
held by the employee for the requisite holding periods described above.

If the Corporation delivers cash, in lieu of fractional shares, the
employee will recognize ordinary income equal to the amount of cash paid. An
amount equal to any such ordinary income will be deductible by the Corporation.

Section 162(m) of the Code, which generally disallows a tax deduction
for compensation over $1,000,000 paid to the Chief Executive Officer and certain
other highly compensated executive officers, provides that "performance-based"
compensation will not be subject to the $1,000,000 deduction limitation. Since
an employer is not entitled to a deduction upon the grant or exercise of an ISO
in any event (except in the case of a disqualified disposition), this provision
generally does not affect the Corporation's tax treatment with regard to ISOs.
Options (other than ISOs) granted under a plan approved by shareholders with an
exercise price equal to the fair market value of the underlying stock as of the
date of grant are considered performance-based compensation, if certain
requirements are met. The 1995 Stock Option Plan meets such requirements and,
accordingly, any income realized by employees with respect to the 1995 Stock
Option Plan is not subject to the deduction limitation of Section 162(m).

The 1995 Stock Option Plan is not subject to any provisions of the
Employee Retirement Income Security Act of 1974 and is not required to be
qualified under Section 401(a) of the Code.

Restrictions on Resale

Registration Under the Securities Act. The Corporation may register the
shares of Common Stock underlying the Options on a Registration Statement on
Form S-8 filed with the Securities and Exchange Commission. The Commission has
indicated that optionees who have acquired shares pursuant to a bona fide public
offering registered on Form S-8 and who are not affiliates of the Corporation,
at the time of their proposed reoffer or resale, may generally resell or reoffer
the shares so acquired. Optionees who are affiliates of the Corporation may
resell or reoffer shares acquired pursuant to an Option only if such reoffer or
resale is made pursuant to an exemption from the registration requirements of
the Securities Act or pursuant to a prospectus which meets the requirements of
General Instruction C of Form S-8. In the case of affiliates, the exemption
provided by Rule 144 under the Securities Act would be available so long as the
Corporation continues to be in compliance with the reporting requirements and
the affiliate complies with the volume limitations and the other requirements of
that rule.

Exemption from Section 16(b) of the Exchange Act. The 1995 Stock Option
Plan meets the requirements of Rule 16b-3 of the Exchange Act, which exempts the
acquisition of certain options under the 1995 Stock Option Plan from the
operation of Section 16(b) under the Exchange Act.

Board Recommendation

The Board of Directors believes that it is in the best interests of the
Corporation and its shareholders to approve the amendment to the 1995 Stock
Option Plan so that the Corporation can continue to attract, retain and motivate
qualified employees and to align their interests with those of the Corporation's
shareholders. Approval of the amendment to the 1995 Stock Option Plan requires
the affirmative vote of a majority of the votes cast at the Annual Meeting.
Accordingly, the Board of Directors recommends that you vote FOR the approval of
the amendment to the 1995 Stock Option Plan.

<PAGE>

OTHER BUSINESS

The Board of Directors of the Corporation knows of no other matters to
be presented at the Annual Meeting. However, if any other matters properly come
before the meeting, or any adjournment thereof, it is intended that proxies in
the accompanying form will be voted in accordance with the judgment of the
persons named therein.

SHAREHOLDER PROPOSALS

Proposals of shareholders intended to be presented at the next annual
meeting of the Corporation's shareholders must be received by the Corporation
for inclusion in the Corporation's 2000 Proxy Statement and form of proxy on or
prior to July 10, 2000.

ANNUAL REPORTS AND FINANCIAL STATEMENTS

The Annual Report to Shareholders of the Corporation for the fiscal
year ended June 30, 1999 (the "Annual Report") is being furnished simultaneously
herewith. Such Annual Report is not to be considered a part of this Proxy
Statement.

Upon the written request of any shareholder, management will provide,
free of charge, a copy of the Corporation's Annual Report on Form 10-K,
including the financial statements and schedules thereto. Requests should be
directed to Secretary, Datascope Corp., 14 Philips Parkway, Montvale, New Jersey
07645.

RELATIONSHIP WITH INDEPENDENT PUBLIC ACCOUNTANTS

The Corporation's financial statements for the years ended June 30,
1999 and 1998 have been examined by the firm of Deloitte & Touche LLP,
independent certified public accountants. Representatives of Deloitte & Touche
LLP are expected to be present at the Annual Meeting of Shareholders to make a
statement if they so desire and they are expected to be available to respond to
appropriate questions.

The Corporation's Board of Directors intends to review the appointment
of independent certified public accountants at a meeting subsequent to the
Annual Meeting of Shareholders.

COST OF SOLICITATION

The cost of soliciting proxies in the accompanying form has been or
will be borne by the Corporation. The Corporation has engaged the firm of
MacKenzie Partners, Inc. as proxy solicitors. The fee to such firm for
solicitation services is estimated to be $8,500 plus reimbursement of
out-of-pocket expenses. In addition, directors, officers and employees of the
Corporation may solicit proxies personally or by telephone or other means of
communication. Although there is no formal agreement to do so, arrangements may
be made with brokerage houses and other custodians, nominees and fiduciaries to
send proxies and proxy material to their principals, and the Corporation may
reimburse them for any attendant expenses.

It is important that your shares be represented at the meeting. If you
are unable to be present in person, you are respectfully requested to sign the
enclosed proxy and return it in the enclosed stamped and addressed envelope as
promptly as possible.

By Order of the Board of Directors,

MURRAY PITKOWSKY,
Secretary

Dated: November 1, 1999
Montvale, New Jersey

<PAGE>

EXHIBIT A

DATASCOPE CORP.
1995 STOCK OPTION PLAN

1. Purpose. The 1995 Stock Option Plan (the "Plan") of Datascope Corp.
(the "Company"), a Delaware corporation, is designed to aid the Company and its
subsidiaries in retaining and attracting personnel of exceptional ability by
enabling key employees to purchase a proprietary interest in the Company,
thereby stimulating in such individuals an increased desire to render greater
services which will contribute to the continued growth and success of the
Company and its subsidiaries. Certain of the options to be granted under the
Plan are intended to satisfy the requirements for classification as "Incentive
Stock Options" as defined in Section 422, of the Internal Revenue Code of 1986,
as amended (the "Code"). (An option granted under the Plan which is intended to
satisfy the requirements for classification as an Incentive Stock Option shall
be referred to herein as a "Plan Incentive Stock Option").

2. Amount and Source of Stock. The aggregate number and class of shares
which may be the subject of options granted pursuant to the Plan is 2,750,000
shares ("Shares") of Common Stock, par value $.01 per share, of the Company,
subject to adjustment as provided in paragraph 10, all of which may be subject
to Plan Incentive Stock Options. Any one participant may be granted Options to
purchase a maximum of 150,000 Shares in any one year, subject to adjustment as
provided in paragraph 10. Such Shares may be reserved or made available from the
Company's authorized and unissued Shares or from Shares reacquired and held in
the Company's treasury. In the event that any option granted hereunder shall
terminate prior to its exercise in full, for any reason, including, without
limitation, an option exchange pursuant to paragraph 13 hereof, or in the event
that any Shares issued upon the exercise of an option granted hereunder shall be
reacquired by the Company as provided in paragraph 12 hereof, then the Shares
subject to the option so exercised or the Shares so reacquired shall be added to
the Shares otherwise available for issuance pursuant to the exercise of options
under the Plan; provided, however, that in the case of a cancellation or
termination of an option in the same fiscal year that such option was granted
(or for purposes of determining the maximum number of options which may be
granted to a participant under the Plan, the cancellation or termination of an
option at any time), both the canceled option and the newly granted option shall
be counted in determining whether the participant has received the maximum
number of options permitted to be issued to any one participant under the Plan.

3. Administration of the Plan. The Plan shall be administered by a
committee of the Board of Directors of the Company (the "Board") comprised of
three or more members of the Board, selected by the Board (the "Committee"). All
of the members of the Committee shall be both "disinterested persons" as that
term is described in Rule 16b-3 (c) (2) (or any successor provision) promulgated
under the Securities Exchange Act of 1934, as amended, and "outside directors"
as that term is defined for purposes of Section 162(m) of the Code (or any
successor provision).

The Committee shall have full authority to interpret the Plan, to
establish and amend rules and regulations relating to it, to determine the key
employees to whom options may be granted under the Plan, to select from among
the eligible individuals those to whom options are to be granted, to determine
the terms and provisions of the respective option agreements (which need not be
identical) and to make all other determinations necessary or advisable for the
administration of the Plan. The Committee, with approval by the Board, shall
have full authority to amend the Plan; provided, however, that any amendment
that (i) increases the number of Shares that may be the subject of stock options
granted under the Plan, (ii) expands that class of individuals eligible to
receive options under the Plan, (iii) increases the period during which options
may be granted or the permissible term of options under the Plan, (iv) decreases
the minimum exercise price of such options, or (v) would require the approval of
Shareholders in order for options granted under the Plan to satisfy the
requirements for performance based compensation for purposes of Code Section
162(m) (4) (C) (or successor provision) shall only be adopted by the Committee
subject to Board and shareholder approval. No amendment to the Plan shall,
without the consent of the holder of an existing option, materially and
adversely affect his or her rights under any option. The date on which the
Committee, adopts resolutions granting an option to a specified individual shall
constitute the date of grant of such option (the "Date of Grant"); provided,
however, that if the grant of an option is made subject to the occurrence of a
subsequent event (such as, for example, the commencement of employment), the
date on which such subsequent event occurs shall be the Date of Grant. Such
resolutions shall also specify whether the option is or is not intended to
qualify as a Plan Incentive Stock Option; provided, however, that in the event
no such specification is made in such resolutions the Committee, will be deemed
to have specified that such option is intended to qualify as a Plan Incentive
Stock Option; provided, further, however that in the event the Code's
requirements for qualification as an Incentive Stock Option are inconsistent
with the terms of an option that is specified, whether explicitly or implicitly,
as intended to qualify as a Plan Incentive Stock Option, then such specification
shall be deemed changed to the minimum extent necessary to be consistent with
such requirements of the Code. The adoption of any such resolution by the
majority of the members of the Committee shall complete the necessary corporate
action constituting the grant of said option and an offer of Shares for-sale to
said individual under the Plan.

4. Eligibility. All officers and key employees of the Company or
subsidiaries of the Company, as determined by the Committee, shall be eligible
to receive options hereunder, provided, however, that no Plan Incentive Stock
Option shall be granted hereunder to any person who immediately at the time of
the grant of such option and assuming its immediate exercise, would beneficially
own, within the meaning of Section 424(d) of the Code, Shares possessing more

<PAGE>

than ten percent (10%) of the total combined voting power of all of the
outstanding Common Stock of the Company ("Ten Percent Shareholder"), unless the
option granted to the Ten Percent Shareholder satisfies the additional
conditions for options granted to Ten Percent Shareholders set forth in
subparagraphs 5(a) and 6(a) hereof. For purposes of the Plan, a subsidiary shall
mean any "subsidiary corporation" as defined in Section 424(f) of the Code and,
in addition, with respect to any option under the Plan that is not an Incentive
Stock Option, any partnership of which the Company or any subsidiary of the
Company is a general partner. From time to time the Committee shall, in its sole
discretion, within the applicable limits of the Plan, select from among the
eligible individuals those persons to whom options shall be granted under the
Plan, the number of Shares subject to each option, and the exercise price, terms
and conditions of any options to be granted hereunder.

5. Option, Price, Maximum Grant.

(a) The exercise price for the Shares purchasable under options granted
pursuant to the Plan shall not be less than 100%, or, in the case of a Plan
Incentive Stock Option granted to a Ten Percent Shareholder, 110% of the fair
market value per share of the Shares subject to option under the Plan at the
Date of Grant, solely as determined by the Committee in good faith. The exercise
price for options granted pursuant to the Plan shall be subject to adjustment as
provided in paragraph 10.

(b) To the extent necessary for any Plan Incentive Stock Options to
qualify as Incentive Stock Options, the aggregate fair market value, determined
as of the Date of Grant, of the Shares subject to such options which may first
become exercisable by an individual in any calendar year, under this Plan and
all other stock option plans of the Company and of any parent or subsidiary of
the Company pursuant to which Incentive Stock Options may be granted, shall not
exceed $100,000.

6. Term of Option.

(a) Subject to the provisions of the Plan, the Committee shall have
absolute discretion in determining the period during which, the rate at which
and the terms and conditions upon which any option granted hereunder may be
exercised, and whether any option exercisable in installments is to be
exercisable on a cumulative or noncumulative basis; provided, however, that no
option granted hereunder shall be granted within ten (10) years of the earlier
of the date on which this Plan is adopted or the date on which this Plan is
approved by the shareholders. It is further provided that no option granted
herein under shall be exercisable after the expiration of ten (10) years or, in
the case of a Plan Incentive Stock Option granted to a Ten Percent Shareholder,
five (5) years from the Date of Grant. Unless the resolution granting an option
provides otherwise, each option granted hereunder shall, subject to the
provisions of paragraph 8 hereof, be exercisable for a period of ten (10) years
or, in the case of a Plan Incentive Stock Option granted to a Ten Percent
Shareholder, five (5) years from the Date of Grant.

(b) The grant of options by the Committee shall be effective as of the
date on which the Committee shall authorize the option; provided, however, that
no options granted hereunder shall be exercisable unless and until the holders
shall enter into individual option agreements with the Company that shall set
forth the terms and conditions of such options. Each such agreement shall
expressly incorporate by reference the provisions of this Plan and shall state
that in the event of any inconsistency between the provisions hereof and the
provisions of such agreement, the provisions of this Plan shall govern.

7. Exercise of Options. An option shall be exercised when written
notice of such exercise, signed by the person entitled to exercise the option,
has been delivered or transmitted by registered or certified mail to the
Secretary of the Company at its then principal office. Said notice shall specify
the number of Shares for which the option is being exercised and shall be
accompanied by (i) such documentation, if any, as may be required by the Company
as provided in subparagraph 11 (b), and (ii) payment of the aggregate option
price. Such payment shall be in the form of (i) cash or a certified check
(unless such certification is waived by the Company) payable to the order of the
Company in the amount of the aggregate option price, (ii) certificates duly
endorsed for transfer (with all transfer taxes paid or provided for) evidencing
a number of shares of Common Stock of the Company of which the aggregate market
value on the date of exercise is equal to the aggregate option exercise price of
the shares being purchased, or (iii) a combination of these methods of payment;
provided, however, that payment, whether in whole or in part, by surrendering
certificates, may only be made if the optionee has held such shares for a period
of at least 6 months prior to the date of surrender. Delivery of said notice
shall constitute an irrevocable election to purchase the Shares specified in
said notice, and the date on which the Company receives the last of said notice,
documentation and the aggregate option exercise price for all of the shares
covered by the notice shall, subject to the provisions of paragraph 11 hereof,
be the date as of which the Shares so purchased shall be deemed to have been
issued. The person entitled to exercise the option shall not have the right or
status as a holder of the Shares to which such exercise relates prior to receipt
by the Company of the payment, notice and documentation expressly referred to in
this paragraph 7.

8. Exercise and Cancellation of Options Upon Termination of Employment
or Death. Except as set forth below, if a holder shall voluntarily or
involuntarily terminate his service as an employee of the Company or any
subsidiary of the Company, the option of such holder shall terminate upon the
date of such termination of employment regardless of

<PAGE>

the expiration date specified in such option. If the termination of employment
is due to retirement (as defined by the Committee in its sole discretion), the
holder shall have the privilege of exercising any option that which the holder
could have exercised on the day upon which he ceased to be an employee of the
Company or any subsidiary of the Company, provided, however, that such exercise
must be accomplished within the term of such option and within three (3) months
of the holder's retirement. If the termination of employment is due to
disability (to an extent and in a manner as shall be determined by the Committee
in its sole discretion), he (or his duly appointed guardian or conservator)
shall have the privilege of exercising any option that he could have exercised
on the day upon which he ceased to be an employee of the Company or any
subsidiary of the Company; provided, however, that such exercise must be
accomplished within the term of such option and within one (1) year of the
termination of his employment with the Company or any subsidiary of the Company.
If the termination of employment is due to the death of the holder, the duly
appointed executor or administrator of his estate shall have the privilege at
any time of exercising any option that the holder could have exercised on the
date of his death; provided, however, that such exercise must be accomplished
within the term of such option and within one (1) year of the holder's death.
For all purposes of the Plan, an approved leave of absence shall not constitute
interruption or termination of employment. Nothing contained herein or in any
option agreement shall be construed to confer on any option holder any right to
be continued in the employ of the Company or any subsidiary of the Company or
derogate from any right of the Company or any subsidiary of the Company to
retire, request the resignation of or discharge such option holder or to lay off
or require a leave of absence of such option holder(with or without pay), at any
time, with or without cause.

8A. Election to Have Shares Withheld.

(a) A holder may elect to have Shares withheld by the Company in order
to satisfy federal and state withholding tax liability (a "share withholding
election"), provided, (i) the Committee shall not have revoked its advance
approval of the holder's share withholding election; and (ii) the share
withholding election is made on or prior to the date on which the amount of
withholding tax liability is determined (the "Tax Date"). If a holder elects
within thirty (30) days of the date of exercise to be subject to withholding tax
on the exercise date pursuant to the provisions of Section 83(b) of the Code,
then the share withholding election may be made during such thirty (30) day
period. Notwithstanding the foregoing, a holder whose transactions in Common
Stock are subject to Section 16(b) of the Securities Exchange Act of 1934 may
make a share withholding election only if the following additional conditions
are met: (i) the share withholding election is made no sooner than six (6)
months after the Date of Grant, except, however, such six (6) month condition
shall not apply if the holder's death or disability (as shall be determined by
the Committee) occurs within such six (6) month period; and (ii) the share
withholding election is made (x) at least six (6) months prior to the Tax Date,
(y) during the period beginning on the third business day following the date of
release of the Company's quarterly or annual financial results and ending on the
twelfth business day following such date.

(b) A share withholding election shall be deemed made when written
notice of such election, signed by the holder, has been hand delivered or
transmitted by registered or certified mail to the Secretary of the Company at
its then principal office. Delivery of said notice shall constitute an
irrevocable election to have Shares withheld.

(c) Upon exercise of an option by a holder, the Company shall transfer
the total number of Shares subject to the option to the holder on the date of
exercise, provided, however, that pursuant to subparagraph (d) below, the holder
will be unconditionally obligated to tender shares back to the Company.

(d) If a holder has made a share withholding election pursuant to this
Section 8A; and (i) within thirty (30) days of the date of exercise of the
option, the holder elects pursuant to the provisions of Section 83 (b) of the
Code to be subject to withholding tax on the date of exercise of his option,
then such holder will be unconditionally obligated to immediately tender back to
the Company the number of Shares having an aggregate fair market value (as
determined in good faith by the Committee) equal to the amount of tax required
to be withheld plus cash for any fractional amount, together with written notice
to the Company informing the Company of the holder's election pursuant to
Section 83(b) of the Code; or (ii) if the holder has not made an election
pursuant to the provisions of Section 83 (b) of the Code, then on the Tax Date,
such holder will be unconditionally obligated to tender back to the Company the
number of Shares having an aggregate fair market value (as determined in good
faith by the Committee) equal to the amount of tax required to be withheld plus
cash for any fractional amount.

9. Non-transferability of Options. No option granted under the Plan
shall be sold, pledged, assigned or transferred in any manner except to the
extent that options may be exercised by an executor or administrator as provided
in paragraph 8 hereof. An option may be exercised, during the lifetime of the
holder thereof, only by such holder or his duly appointed guardian or
conservator in the event of his disability.

<PAGE>

10. Adjustments Upon Changes in Capitalization.

(a) If the outstanding Shares are subdivided, consolidated, increased,
decreased, changed into, or exchanged for a different number or kind of shares
or other securities of the Company through reorganization, merger,
recapitalization, reclassification, capital adjustment or otherwise, or if the
Company shall issue additional Shares as a dividend or pursuant to a stock
split, then the number and kind of Shares available for issuance pursuant to the
exercise of options to be granted under this Plan and all Shares subject to the
unexercised portion of any option theretofore granted and the option price of
such options shall be adjusted to prevent the inequitable enlargement or
dilution of any rights hereunder; provided, however, that any such adjustment in
outstanding options under the Plan shall be made without change in the aggregate
exercise price applicable to the unexercised portion of any such outstanding
option. No such adjustment shall be made that(i) with respect to a Plan
Incentive Stock Option, would violate Code Section 422, or successor provision
or(ii) would constitute a cancellation and reissuance of an option for purposes
of Code Section 162(m) to the extent such reissuance would result in the grant
of options in excess of the maximum number of options permitted to be granted to
any participant under the Plan. Distributions to the Company's Shareholders
consisting of property other than shares of Common Stock of the Company or its
successor and distributions to Shareholders of rights to subscribe for Common
Stock shall not result in the adjustment of the Shares purchasable under
outstanding options or the exercise price of outstanding options. Adjustments
under this paragraph shall be made by the Committee whose determination thereof
shall be conclusive and binding. Any fractional Share resulting from adjustments
pursuant to this paragraph shall be eliminated from any then outstanding option.
Nothing contained herein or in any option agreement shall be construed to affect
in any way the right or power of the Company to make or become a party to any
adjustments, reclassifications, reorganizations or changes in its capital or
business structure or to merge, consolidate, dissolve, liquidate or otherwise
transfer all or any part of its business or assets.

(b) If, in the event of a merger or consolidation, the Company is not
the surviving corporation, and in the event that the agreements governing such
merger or consolidation do not provide for the substitution of new options or
other rights in lieu of the options granted hereunder or for the express
assumption of such outstanding options by the surviving corporation, or in the
event of the dissolution or liquidation of the Company, the holder of any option
theretofore granted under this Plan shall have the right not less than five (5)
days prior to the record date for the determination of Shareholders entitled to
participate in such merger consolidation, dissolution or liquidation, to
exercise his option, in whole or in part, without regard to any installment
provision that may have been made part of the terms and conditions of such
option; provided, that any conditions precedent to such exercise set forth in
any option agreement granted under this Plan, other than the passage of time,
have been satisfied. In any such event, the Company will mail or cause to be
mailed to each holder of an option hereunder a notice specifying the date that
is to be fixed as of which all holders of record of the Shares shall be entitled
to exchange their shares for securities, cash or other property issuable or
deliverable pursuant to such merger, consolidation, dissolution or liquidation.
Such notice shall be mailed at least ten (10) days prior to the date therein
specified. In the event any then outstanding option is not exercised in its
entirety on or prior to the date specified therein, all remaining outstanding
options granted hereunder and any and all rights thereunder shall terminate as
of said date.

11. General Restrictions.

(a) No option granted hereunder shall be exercisable if the Company
shall, at any time in its sole discretion, determine that (i) the listing upon
any securities exchange, registration or qualification under any state or
federal law of any Shares otherwise deliverable upon such exercise, or (ii) the
consent or approval of any regulatory body or the satisfaction of withholding
tax or other withholding liabilities, is necessary or appropriate in connection
with such exercise. In any of such events, the exercisability of such actions
shall be suspended and shall not be effective unless and until such withholding,
listing, registration, qualification or approval shall have been effected or
obtained free of any conditions not acceptable to the Company in its sole
discretion, notwithstanding any termination of any option or any portion of any
option during the period when exercisability has been suspended.

(b) The Committee may require, as a condition to the right to exercise
an option, that the Company receive from the option holder, at the time of any
such exercise, representations, warranties and agreements to the effect that the
Shares are being purchased by the holder only for investment and without any
present intention to sell or otherwise distribute such Shares and that the
option holder will not dispose of such Shares in transactions which, in the
opinion of counsel to the Company, would violate the registration provisions of
the Securities Act of 1933, as then amended, and the rules and regulations
thereunder. The certificate issued to evidence such Shares shall bear
appropriate legends summarizing such restrictions on the disposition thereof.

12. Restrictions on Transfers of Shares; Repurchase by the Company.

(a) Without the prior written consent of the Company, the individual
exercising an option hereunder shall not sell, transfer, pledge, hypothecate or
otherwise dispose of any Shares acquired upon the exercise of options hereunder
or any interest in any such Shares within seven (7) months following the date of
such exercise. In the event that during the first six months of such period the
option holder shall, for any reason (other than death), cease to be an officer
or employee of the Company or its subsidiaries, then forthwith upon the
occurrence of such event, the Company shall have

<PAGE>

the right for the duration of such seven month period to repurchase from the
option holder, and upon the exercise of such right, the option holder shall be
required to sell to the Company, all such Shares owned by him which are then
subject to restriction under this subparagraph 12(a) for a price equal to the
aggregate exercise price paid for such Shares. The Company may exercise its
right to repurchase shares by mailing notice of exercise to the option holder
prior to the expiration of the Company's repurchase right. In the event the
Company repurchases such Shares, the certificate or certificates evidencing such
Shares shall forthwith be delivered to the Company against full payment of~the
sum of (i) an amount of money in the form of cash or check equal to the amount,
if any, paid by the optionee in cash or check as payment of the exercise price,
and (ii) a number of Shares equal to the number of Shares, if any, paid by the
optionee as payment of the exercise price, without regard to the then fair
market value of such Shares. In the event the optionee had paid the option
exercise price, in whole or in part, in Shares, then the Company shall delay
such repurchase until six (6) months and ten (10) days from the date the
optionee ceased to be an officer or employee of the Company or its subsidiaries.

(b) The certificate or certificates delivered to individuals who
exercise options hereunder to evidence Shares acquired upon any exercise of an
option (as provided in paragraph 7 hereof) shall bear, in addition to any
restrictive legend required by subparagraph 11 (b) hereof, a legend summarizing
the restrictions set forth in subparagraph (a) of this paragraph 12.

(c) In the event of the death of an option holder, all restrictions set
forth in subparagraph (a) and provided for in subparagraph (b) of this paragraph
shall terminate forthwith with respect to any and all Shares owned by such
holder at the date of his death, but neither the termination of such
restrictions upon the death of the holder nor any lapse of restrictions upon the
expiration of any period specified in subparagraph 12(a) hereof shall affect the
obligations of the holder (or his executor or administrator) to comply with the
requirements of subparagraph 11 (b) in connection with any sale or other
disposition of any such Shares.

(d) Anything in the Plan to the contrary notwithstanding, the
Committee, shall have the power, in its discretion, to lessen or eliminate the
period of time during which the transfer of a holder's Shares is restricted
under, and/or to eliminate or modify in the holder's favor the Company's right
to repurchase Shares pursuant to, this paragraph 12, whether before or after any
option is granted or exercised hereunder.

13. Exchange of Options. The Committee shall have the right to grant
options hereunder that are granted subject to the condition that the grantee
shall agree with the Company to terminate all or a portion of another option or
options previously granted under the Plan. The Shares that had been issuable
pursuant to the exercise of the option terminated in the exchange of options
shall, upon such termination, again become available for issuance pursuant to
the exercise of options under the Plan.

14. Termination. Unless the Plan shall theretofore have been terminated
as hereinafter provided, the Plan shall terminate on September 17, 2005, and no
options under the Plan shall thereafter be granted, provided, however, the Board
at any time may, in its sole discretion, terminate the Plan prior to the
foregoing date. No termination of the Plan shall, without the consent of the
holder of an existing option, materially and adversely affect his rights under
such option.

The Plan shall be submitted to the Shareholders of the Company for
approval in accordance with the applicable provisions of the Delaware General
Corporation Law as promptly as practicable and in any event within one year
after the date of the original adoption hereof by the Board. Any options granted
hereunder prior to such shareholder approval shall not be exercisable unless and
until such approval is obtained. If such approval is not obtained within such
time period, the Plan and any options granted hereunder shall be terminated.

<PAGE>

PROXY DATASCOPE CORP. COMMON STOCK

PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
OF THE CORPORATION FOR THE ANNUAL MEETING OF STOCKHOLDERS
DECEMBER 7, 1999

The undersigned hereby constitutes and appoints LAWRENCE SAPER
and MURRAY PITKOWSKY, and each of them, with full power of substitution,
attorneys and proxies to represent and to vote all of the shares of common
stock, par value $.01 per share, of DATASCOPE CORP. that the undersigned would
be entitled to vote, with all powers the undersigned would possess if personally
present, at the Annual Meeting of the Shareholders of DATASCOPE CORP., to be
held at The Harmonie Club, 4 East 60th Street, New York, New York, on December
7, 1999 at 11:00 o'clock a.m., local time, and at any adjournment thereof, on
all matters coming before said meeting:

1. ELECTION OF DIRECTORS. Nominees: David Altschiller and Joseph
Grayzel, M.D. (Mark only one of the following boxes.)

|_| VOTE FOR all nominees listed above, except vote
withheld as to the following nominees (if any):
__________________

|_| VOTE WITHHELD from all nominees.

2. PROPOSAL TO APPROVE THE AMENDMENT TO THE DATASCOPE CORP. 1995
STOCK OPTION PLAN.

|_| FOR |_| AGAINST |_| ABSTAIN

3. In their discretion, upon any other business that may properly
come before the meeting or any adjournment thereof.

(Continue and sign on other side)

<PAGE>

(Continued from other side)

This proxy when properly executed will be voted in the manner
directed herein by the undersigned shareholder. If no direction is made, this
proxy will be voted FOR the election as directors of the nominees of the Board
of Directors and FOR the proposal to approve the amendment to the Datascope
Corp. 1995 Stock Option Plan.

The undersigned acknowledges receipt of the accompanying Proxy
Statement dated November 1, 1999.

Dated: ____________________, 1999

_________________________________

_________________________________
Signature of Shareholder(s)

(When signing as attorney,
trustee, executor,
administrator, guardian,
corporate officer, etc., please
give full title. If more than
one trustee, all should sign.
Joint owners must each sign.)
Please date and sign exactly as
name appears above.
I plan |_| I do not plan |_| to attend
the Annual Meeting.